Recent Company News

• 09:17 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:18 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:18 AM ET May 07, 2025
  

  Immunocore Holdings reports Q1 EPS $0.10 vs FactSet ($0.38) [16 est, ($0.51)-(0.20)] ($28.06, 0.00)

• 10:25 AM ET Apr 09, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (697 total)

• 10:18 AM ET Apr 07, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (1167 total)

• 05:00 PM ET Apr 02, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:28 AM ET Mar 20, 2025
  

  Immunocore Holdings holder Baker Bros discloses buying 747K shares (yesterday post-close) ($28.71, 0.00)

• 10:08 AM ET Mar 11, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (156 total)

• 03:04 PM ET Mar 10, 2025
  

  Immunocore Holdings presents initial multiple ascending dose data for HIV functional cure candidate IMC-M113V at CROI 2025 ($29.24, -0.56)

• 07:10 AM ET Feb 26, 2025
  

  Immunocore Holdings reports Q4 EPS ($0.47) vs FactSet ($0.24) [16 est, ($0.93)-0.09] ($29.21, 0.00)